Corvus Pharmaceuticals, Inc.
← Back to CRVS Overview

Corvus Pharmaceuticals, Inc. (CRVS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-24.38

Financial Fundamentals

CRVSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-12-31-7.27
2015-03-31-16.19
2015-06-30-1.57
2015-09-30-10.18
2015-12-31-5.24
2016-03-31-0.67
2016-06-30-8.29
2016-09-30-8.06
2016-12-31-6.50
2017-03-31-6.57
2017-06-30-4.14
2017-09-30-6.43
2017-12-31-4.47
2018-03-31-4.58
2018-06-30-6.86
2018-09-30-5.71
2018-12-31-2.55
2019-03-31-2.50
2019-06-30-2.36
2019-09-30-2.03
2019-12-31-3.58
2020-03-31-1.20
2020-06-30-1.89
2020-09-30-3.04
2020-12-310.97
2021-03-31-2.26
2021-06-30-2.38
2021-09-30-5.04
2021-12-31-3.01
2022-03-31-2.28
2022-06-30-1.38
2022-09-30-0.64
2022-12-31-1.01
2023-03-31-1.34
2023-06-30-4.09
2023-09-30-3.04
2023-12-31-3.24
2024-03-31-3.88
2024-06-30-6.61
2024-09-30-2.20
2024-12-31-7.43
2025-03-313.79
2025-06-30-10.00
2025-09-30-15.35
2025-12-31-10.69
2026-03-31-24.38

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.